Cyclophosphamide monotherapy in children with Burkitt lymphoma: A study from the French–African Pediatric Oncology Group (GFAOP)
Authors:
- 5 November 2010
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 56 (1) , 70-76
Abstract
Background: The French African Group of Pediatric Oncology was set‐up to improve quality of care for children with cancer. Preliminary observations on the efficacy in Burkitt lymphoma (BL) of a cyclophosphamide monotherapy (CPM) have been published. We report the results of a multicentric prospective study combining first‐line CPM and a multidrug second‐line chemotherapy (SC) for refractory/relapsed patients.Procedure: Patients ≤18 years with Burkitt or Burkitt‐like lymphoma, were included in six countries (Burkina‐Faso, Cameroon, Ivory Coast, Madagascar, Mali, and Senegal). All patients received three weekly CPM courses (1.2 g/m2 IV with intrathecal methotrexate and hydrocortisone), stage 3/4 patients received three further courses. SC added methotrexate, vincristine, cytarabine, and prednisone.Results: There were 178 patients included (42 stage 1/2, 134 stage 3/4, and 2 unknown). Isolated facial localization was found in 41 patients, diffuse abdominal involvement in 120 patients including 65 with both. Nine early deaths were reported, toxicity occurred in 136/743 courses (83 patients) and was predominantly hematological. After CPM, complete remission (CR) rate was 47% with a 33% EFS. Because of rapid progression 76/108 eligible patients (85 primary refractory and 23 relapses) received SC resulting in 35.7% CR but a 21% toxic death rate. The OS of the whole strategy was 50.5% and correlated to stage.Conclusion: A prospective multicentric study on BL was feasible in very low‐income countries. CPM can be recommended in stage 1–2 because of optimal cost/benefit ratio. However, more intensive strategies, still adapted to socio‐economic conditions, are required for advanced stages 3 and 4. Pediatr Blood Cancer. 2010;56:70–76.Keywords
This publication has 21 references indexed in Scilit:
- Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: a descriptive studyThe Lancet Oncology, 2008
- Treatment of B‐cell lymphoma with LMB modified protocols in Africa—report of the French‐African Pediatric Oncology Group (GFAOP)Pediatric Blood & Cancer, 2008
- Le groupe franco-africain d'oncologie pédiatrique : bilan d'une première étapeArchives de Pédiatrie, 2005
- Socioeconomic constraints to effective management of Burkitt's lymphoma in south‐eastern NigeriaTropical Medicine & International Health, 2005
- The 2000 Burkitt lymphoma trial in MalawiPediatric Blood & Cancer, 2004
- Cancer incidence among children in France, 1990–1999Pediatric Blood & Cancer, 2004
- Long term survival of children with Burkitt lymphoma in Malawi after cyclophosphamide monotherapyMedical and Pediatric Oncology, 2002
- Burkitt's Lymphoma: A Case File Study of 160 Patients Treated in Queen Elizabeth Central Hospital from 1988 to 1992Pediatric Hematology and Oncology, 1995
- A sarcoma involving the jaws in african childrenBritish Journal of Surgery, 1958
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958